Advani AS - Search Results

1

SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia.

Advani AS, McDonough S, Coutre S, Wood B, Radich J, Mims M, O'Donnell M, Elkins S, Becker M, Othus M, Appelbaum FR. Advani AS, et al. Br J Haematol. 2014 May;165(4):504-9. doi: 10.1111/bjh.12778. Epub 2014 Mar 3. Br J Haematol. 2014. PMID: 24579885 Free PMC article. Clinical Trial.

2

A Phase 1 study of imatinib mesylate in combination with cytarabine and daunorubicin for c-kit positive relapsed acute myeloid leukemia.

Advani AS, Tiu R, Saunthararajah Y, Maciejewski J, Copelan EA, Sobecks R, Sekeres MA, Bates J, Rush ML, Tripp B, Salvado A, Noon E, Howard M, Jin T, Hsi E, Egorin MJ, Lim K, Cotta CV, Price C, Kalaycio M. Advani AS, et al. Leuk Res. 2010 Dec;34(12):1622-6. doi: 10.1016/j.leukres.2010.03.021. Epub 2010 Apr 27. Leuk Res. 2010. PMID: 20427086 Clinical Trial.

3

Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia.

Advani AS, Gundacker HM, Sala-Torra O, Radich JP, Lai R, Slovak ML, Lancet JE, Coutre SE, Stuart RK, Mims MP, Stiff PJ, Appelbaum FR. Advani AS, et al. Br J Haematol. 2010 Dec;151(5):430-4. doi: 10.1111/j.1365-2141.2010.08387.x. Br J Haematol. 2010. PMID: 21113977 Free PMC article. Clinical Trial.

4

Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL).

Advani AS, Gibson S, Douglas E, Diacovo J, Elson P, Kalaycio M, Copelan E, Sekeres M, Sobecks R, Sungren S, Lagoo A, Rizzieri D, Hsi E. Advani AS, et al. Br J Haematol. 2011 May;153(4):504-7. doi: 10.1111/j.1365-2141.2011.08607.x. Epub 2011 Mar 6. Br J Haematol. 2011. PMID: 21375525 Free article.

5

Antibody therapy for acute lymphoblastic leukemia.

Portell CA, Advani AS. Portell CA, et al. Among authors: advani as. Curr Hematol Malig Rep. 2012 Jun;7(2):153-9. doi: 10.1007/s11899-012-0120-7. Curr Hematol Malig Rep. 2012. PMID: 22422550 Review.

6

Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia.

Sun D, Elson P, Liedtke M, Medeiros BC, Earl M, Alizadeh A, Bates J, Sekeres MA, Coutre S, Kalaycio M, Sobecks R, Copelan E, Advani AS. Sun D, et al. Among authors: advani as. Am J Hematol. 2012 Oct;87(10):957-60. doi: 10.1002/ajh.23279. Epub 2012 Jun 22. Am J Hematol. 2012. PMID: 22729847 Free article.

7

Biology and treatment of acute lymphocytic leukemia in adolescents and young adults.

Advani AS. Advani AS. Am Soc Clin Oncol Educ Book. 2013:285-9. doi: 10.14694/EdBook_AM.2013.33.285. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714524 Free article. Review.

8

Novel targeted therapies in acute lymphoblastic leukemia.

Portell CA, Advani AS. Portell CA, et al. Among authors: advani as. Leuk Lymphoma. 2014 Apr;55(4):737-48. doi: 10.3109/10428194.2013.823493. Epub 2013 Aug 28. Leuk Lymphoma. 2014. PMID: 23841506 Review.

9

New immune strategies for the treatment of acute lymphoblastic leukemia: antibodies and chimeric antigen receptors.

Advani AS. Advani AS. Hematology Am Soc Hematol Educ Program. 2013;2013:131-7. doi: 10.1182/asheducation-2013.1.131. Hematology Am Soc Hematol Educ Program. 2013. PMID: 24319174 Review.

10

SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia.

Advani AS, McDonough S, Copelan E, Willman C, Mulford DA, List AF, Sekeres MA, Othus M, Appelbaum FR. Advani AS, et al. Br J Haematol. 2014 Oct;167(2):233-7. doi: 10.1111/bjh.13035. Epub 2014 Jul 18. Br J Haematol. 2014. PMID: 25039477 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page